0 270

Cited 16 times in

Effect of bradykinin on cultured bovine corneal endothelial cells

 Yang S.W.  ;  Lee W.K.  ;  Lee E.J.  ;  Kim K.Y.  ;  Lim Y.  ;  Lee K.H.  ;  Rha H.K.  ;  Hahn T.W. 
 OPHTHALMOLOGICA, Vol.215(4) : 303-308, 2001 
Journal Title
Issue Date
Animals ; Bradykinin/analogs & derivatives ; Bradykinin/pharmacology* ; Bradykinin Receptor Antagonists ; Calcium/metabolism ; Cattle ; Cell Count ; Cell Division/drug effects ; Cells, Cultured ; Dose-Response Relationship, Drug ; Egtazic Acid/pharmacology ; Endothelium, Corneal/cytology ; Endothelium, Corneal/drug effects* ; Endothelium, Corneal/metabolism ; Estrenes/pharmacology ; Inositol 1,4,5-Trisphosphate/metabolism ; Pyrrolidinones/pharmacology ; Receptor, Bradykinin B2 ; Receptors, Bradykinin/metabolism ; Signal Transduction/drug effects ; Type C Phospholipases/antagonists & inhibitors ; Type C Phospholipases/metabolism
Bradykinin ; Bovine corneal endothelial cell ; Calcium mobilization ; Bk2 receptor
PURPOSE: To clarify the effect of bradykinin on cytosolic free calcium mobilization and cell proliferation in cultured bovine corneal endothelial cells (BCEC). METHODS: The cytosolic free calcium concentration (Ca2+]i) was measured with the InCa(TM) Imaging System after the treatment of bradykinin (10(-11) to 10(-7) M) alone or with the pretreatments of EGTA, bradykinin receptor (Bk1 and Bk2) antagonists and an inhibition of phospholipase C (U-73122). Also, the effect of bradykinin on cell proliferation in BCEC was evaluated using cell counts. RESULTS: In BCEC, [Ca2+]i in the resting state was 87 +/- 9 nM. Bradykinin induced an increment of [Ca2+]i in a concentration-dependent manner and its 50% effective concentration was approximately 5 x 10(-11) M. A [Ca2+]i increment at 10(-8) M bradykinin was inhibited with the pretreatment of EGTA, an extracellular calcium chelator. U-73122 (5 x 10(-6) M) attenuated the bradykinin-induced [Ca2+]i increment. The pretreatment of HOE-140 (Bk2 antagonist) almost attenuated the bradykinin (10(-8) M)-induced [Ca2+]i increase, but des-Arg9-[Leu(8)]-bradykinin (Bk1 antagonist) did not suppress it. To investigate the physiological effect of bradykinin, the effect of bradykinin on cell proliferation was studied. 10(-8) M of bradykinin produced a significant increase in cell numbers. This mitogenic effect of bradykinin was inhibited by the Bk2 antagonist. CONCLUSIONS: Bradykinin-induced stimulation of the signal transduction pathway in BCEC is coupled with the Bk2 type receptor. Furthermore, bradykinin produces the mitogenic effect in BCEC.
Full Text
Appears in Collections:
1. College of Medicine (의과대학) > Medical Research Center (임상의학연구센터) > 1. Journal Papers
Yonsei Authors
Lee, Woon Kyu(이운규)
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.